Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · IEX Real-Time Price · USD

2.550

+0.030 (1.19%)

At close: Jul 19, 2024, 12:00 AM

2.590

+0.040 (1.57%)

Pre-market: Jul 22, 2024, 8:28 AM EDT

Oramed Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	2018 - 2006
Net Income	10.46	5.53	-36.56	-22.24	-11.51	-14.36	Upgrade
Depreciation & Amortization	0.22	0.2	0.06	0.08	0.01	0.01	Upgrade
Share-Based Compensation	5.33	4.21	11.51	2.7	0.47	0.81	Upgrade
Other Operating Activities	-22.23	-20.23	-2.92	-1.72	-1.4	0.6	Upgrade
Operating Cash Flow	-6.22	-10.3	-27.92	-21.18	-12.44	-12.94	Upgrade
Capital Expenditures	-0.06	-0.25	-0.47	-0.38	-0.08	-0.02	Upgrade
Change in Investments	-29.78	-72.78	30.68	-23.39	4.71	11.28	Upgrade
Other Investing Activities	-	-	0	-0	-0	-0	Upgrade
Investing Cash Flow	-29.84	-73.04	30.21	-23.76	4.63	11.26	Upgrade
Share Issuance / Repurchase	-0	2.43	11.56	101.39	23.79	0	Upgrade
Debt Issued / Paid	30.55	49.55	0	0	0	0	Upgrade
Other Financing Activities	-	-	-0.78	1.5	-	-	Upgrade
Financing Cash Flow	30.55	51.98	10.78	102.89	23.79	0	Upgrade
Exchange Rate Effect	-0.02	-0.05	-0.06	0	-0.01	0.01	Upgrade
Net Cash Flow	-5.53	-31.41	13.01	57.95	15.97	-1.67	Upgrade
Free Cash Flow	-6.28	-10.55	-28.39	-21.56	-12.52	-12.96	Upgrade
Free Cash Flow Margin	-931.60%	-787.24%	-1050.31%	-797.48%	-462.07%	-479.28%	Upgrade
Free Cash Flow Per Share	-0.15	-0.26	-0.73	-0.76	-0.61	-0.74	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).